Amy S. Shah, MD, MS

My Biography & Research

Biography

Dr. Shah is a board-certified pediatric endocrinologist and clinical lipidologist. She is also director of the Adolescent Type 2 Diabetes Program at Cincinnati Children's Hospital Medical Center. Her research focuses on best medial treatments for youth with type 2 diabetes, the effects of bariatric surgery in youth- onset type 2 diabetes, and the effects of youth onset type 2 diabetes on cardiovascular risk. Dr. Shah has active clinical and basic science research programs. Dr. Shah has received several prestigious awards including Young Investigator Awards from The International Society of Pediatric and Adolescent Diabetes Young Investigator Award, The National Lipid Association, The American Society of Clinical Investigation and The Central Society for Clinical and Translational Research. She enjoys teaching and mentoring students, residents and endocrine fellows.

Clinical Interests

Type 2 diabetes; obesity; primary and secondary lipid disorders; hypertension; general endocrinology

Research Interests

Type 2 diabetes; type 1 diabetes; cardiovascular risk factors; lipids and lipoproteins

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Departments

Endocrinology, Endocrinology

My Locations

Burnet Campus

Burnet Campus

3333 Burnet Ave.

Cincinnati, Ohio 45229-3039

513-636-4200

Directions From
Liberty Campus

Liberty Campus

7777 Yankee Road

Liberty Township, Ohio 45044

1-513-803-9600

Directions From

My Education

BA: Biology, The University of Texas at Austin, Austin, TX, 2000.

MD: St. George’s University Medical School, Grenada, West Indies, 2004.

Pediatric Residency: Loyola University Medical Center, Maywood, IL, 2007.

Endocrine Fellowship: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2010.

Research Fellowship: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2011.

MS: Clinical Research, The University of Cincinnati, Cincinnati, OH, 2011.

Certifications: The American Board of Pediatrics, Subspeciality Board in Pediatric Endocrinology, Clinical Lipidology.

My Publications

Burden of Cardiovascular Risk Factors Over Time and Arterial Stiffness in Youth With Type 1 Diabetes Mellitus: The SEARCH for Diabetes in Youth Study. Urbina, EM; Bell, RA; Bowlby, DA; Jr, DR; Daniels, SR; Marcovina, SM; Merchant, AT; Shah, AS; Wadwa, RP; Lawrence, JM; et al. Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease. 2019; 8.

Extremely low levels of low-density lipoprotein potentially suggestive of familial hypobetalipoproteinemia: A separate phenotype of NAFLD?. Mouzaki, M; Shah, A; Arce-Clachar, AC; Hardy, J; Bramlage, K; Xanthakos, SA. Journal of Clinical Lipidology. 2019; 13:425-431.

Youth-Onset Type 2 Diabetes and the Developing Brain. Redel, JM; Dolan, LM; DiFrancesco, M; Vannest, J; Shah, AS. Current Diabetes Reports. 2019; 19.

High-Density Lipoprotein Subspecies in Health and Human Disease: Focus on Type 2 Diabetes. Davidson, WS; Shah, AS. Methodist DeBakey cardiovascular journal. 2019; 15:55-61.

Evaluating a dietary pattern in adolescents with type 1 diabetes mellitus: The dash-d approach. Summer, SS; Couch, SC; Shah, AS; McNeill, MP; Peairs, AD. Diabetes Management. 2019; 9:28-38.

Feasibility of a plasma bioassay to assess oxidative protection of low-density lipoproteins by high-density lipoproteins. Swertfeger, DK; Rebholz, S; Li, H; Shah, AS; Davidson, WS; Lu, LJ. Journal of Clinical Lipidology. 2018; 12:1539-1548.

The early natural history of albuminuria in young adults with youth-onset type 1 and type 2 diabetes. Kahkoska, AR; Isom, S; Divers, J; Mayer-Davis, EJ; Dolan, L; Shah, AS; Afkarian, M; Pettitt, DJ; Lawrence, JM; Marcovina, S; et al. Journal of Diabetes and Its Complications. 2018; 32:1160-1168.

Extracellular Vesicles: A Potential Novel Regulator of Obesity and Its Associated Complications. Kim, A; Shah, AS; Nakamura, T. Children. 2018; 5:152-152.

Prevalence of arterial stiffness in adolescents with type 2 diabetes in the TODAY cohort: Relationships to glycemic control and other risk factors. Shah, AS; El Ghormli, L; Gidding, SS; Bacha, F; Nadeau, KJ; Katz, LE L; Tryggestad, JB; Leibel, N; Hale, DE; Urbina, EM. Journal of Diabetes and Its Complications. 2018; 32:740-745.

A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL. Cooke, AL; Morris, J; Melchior, JT; Street, SE; Jerome, WG; Huang, R; Herr, AB; Smith, LE; Segrest, JP; Remaley, AT; et al. Journal of lipid research. 2018; 59:1244-1255.